A significant decrease was observed in the percentage of cells expressing CX3CR1 in the intermediate CD14++CD16+ subset in patients with mild (75 ± 4; p = 0.002) and moderate (78 ± 3; p = 0.004) asthma compared to healthy (88%) controls (Fig. 5a). Here, CX3CR1 is linked to asthma.